Breast Cancer Diagnostic Market - Industry Analysis, Size, Share, Growth, Trends and Forecast to 2025

Breast cancer is characterized by a malignant tumor formed in the breast cells, which can spread to other parts of the body. Breast cancer is majorly observed in females. Breast cancer is diagnosed by doctors with the help of several tests to locate the site of initiation and the spread of the tumor to several parts of the body. Symptoms of breast cancer includes lump in a breast, change in the shape of breast, skin dimpling, and fluid leakage from the nipple, patches on the skin, etc. Breast cancer can be developed in normal individuals due to several risk factors that involves low physical exertion, alcohol consumption, obesity, menopause, family history and delivering a child at an older age. Breast cancer can be diagnosed at early stages by certain screening tests like yearly mammograms, CT scans, and MRI. Once the symptoms are visually detectable, an individual is advised to undergo diagnostic test to confirm the suspects of the breast cancer. These diagnostic tests are majorly carried out by biopsy in which a small amount of internal tissue is removed from the patient’s body and observed under the microscope to diagnose the breast cancer. This diagnostic method can be carried out with the help of several diagnostic options like that of biopsy, clinical lab tests, ultrasound techniques that are available in the Breast cancer diagnostic market.

Request Sample Copy of the Business Report: https://www.coherentmarketinsights.com/insight/request-sample/425

Alarming rise in incidence of breast cancer augmenting market growth

According to the National Cancer Institute (NCI), 2015, in the U.S. around 232,340 females were encountered with breast cancer and out of which 39,620 cases were lethal. The data from NCI also suggests that 22.9% of female cancers in women accounts to breast cancer while, 18.2% of all the deaths caused due to cancer, contributes to breast cancer. The American Cancer Society (ACS) states that 1 out of 4 patients diagnosed with cancer are victims of breast cancer and is the most commonly observed cancer in females.

Modalities like CT scan and MRI imaging can provide non-invasive, quick and pain free solution for breast cancer diagnosis

The global breast cancer diagnostic market is segmented on the basis of diagnostic type, end user and geography.

On the basis of diagnostic type the global market is segmented as:

1. Ionizing breast imaging technologies: These can be sub- segmented as-

• Analog Mammography
• Full field digital mammography (FFDM)
• 3D breast tomosynthesis
• Positron emission tomography/ Computed tomography (PET/CT)
• Molecular Breast imaging/ breast specific gamma imaging (MBI/BSMI)
• Positron emission mammography
• Others

2. Non ionizing imaging technologies: These can further be sub- segmented as-

• Breast MRI (Magnetic Resonance Imaging)
• Breast Ultrasound
• Optical Imaging
• Automated whole breast ultrasound (AWBU)
• Breast thermography

3. On the basis of end user, the global market can be segmented as-

• Hospitals
• Cancer research centers/ institutes
• Diagnostic Clinical laboratories
• Ambulatory Surgical centers

Increase in incidence of breast cancer worldwide is the prime reason for global breast cancer diagnostic market growth over the forecast period

Regional segmentation of the breast cancer diagnostic market by Coherent Market Insights comprises North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. The major reason driving the breast cancer diagnostic market is the increasing incidence rate of breast cancer all over the globe. The WHO suggests that 89.7 per 100,000 people in Western Europe are affected by breast cancer per year. Apart from this, certain factors like increasing awareness among people regarding regular check- ups for early detection of breast cancer, technological advancement in medical imaging technologies, funding provided by government in research and development of breast cancer treatment and diagnostic techniques are responsible to fuel the global market of breast cancer diagnostics. Moreover, the rise in geriatric population offers high growth to the players of global market. Strikingly, the breast cancer survival rates worldwide are relatively high, making it an important factor that is responsible to drive the breast cancer diagnostic industry. WHO states that survival rates are around 80% in North America, Sweden and Japan. However, as the installation cost of breast cancer diagnostic devices and imaging facilities and side effects of radiation, may result in hindering the growth of the breast cancer diagnostic market.

Browse Research Report At: https://www.coherentmarketinsights.com/ongoing-insight/breast-cancer-diagnostic-market-425

In case of regional segmentation, North America contributes highest in the global breast cancer diagnostic market followed by Europe. The developing countries of the Asia Pacific are potential players in boosting the global market due to factors like growing population of patients, government investments in healthcare expenditure and revenues and awareness among people regarding benefits of early detection of breast cancer.

GE Healthcare to hold one of the dominating position in the competitive breast cancer diagnostic market

Major players dominating the global breast cancer diagnostic market involves Hologic Inc., GE Healthcare, Phillips Healthcare, Fujifilm Holdings Corporation, Gamma Medica Inc., Toshiba Corporation, Aurora Imaging Technology Inc., and Dilion Technologies Inc. GE Healthcare holds a very strong position in the global breast cancer diagnostic industry due to their high investment costs in R&D that results in introduction of advancement in the field.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Neurostimulation Devices Market - Industry Analysis, Size, Share, Growth, Trends and Forecast to 2025

Neurostimulation is therapy used for treatment and diagnosis of disorders of the nervous system. Neurostimulation devices include implantable and non-implantable devices, which deliver chemical, electrical or other agents that reversibly modify nerve cell activity and brain cells. Certain diseases do not respond or react to drug therapies; in such cases advanced neurostimulation devices are used as part of the treatment. Neurostimulation devices are surgically inserted into the patient organs and are controlled with the help of thin wires and leads.

Neurostimulation is used to reduce chronic pains associated with conditions such as Parkinson’s disease, epilepsy, nociceptive pain, neuropathic pain, and depression. It helps improve quality of life of patients suffering from paralysis, obesity, and severe loss of sensory organs. Neurostimulation devices is a key element used in neural prosthetics for artificial vision, artificial limbs, hearing aids, and many more. Neurostimulator is the best therapeutic solution for pain associated with failed back surgery and diabetic neuropathy.

Request Sample Copy of the Business Report: https://www.coherentmarketinsights.com/insight/request-sample/430

As per the data published by European Brain Council, worldwide around 6.3 million people were living with Parkinson’s disease in 2015 and the number is expected to increase steadily in the near future.

Intracranial stimulation, peripheral nerve stimulation (PNS), Spinal cord stimulation (SCS), deep brain stimulation, and motor cortex stimulation are among the most widely used neurostimulation devices. Spinal cord stimulation is widely used in failed back surgery, pain due to peripheral neuropathy, and pain due to low supply of blood to the limb, chest pain, urinary incontinence, and occipital neuralgia. The deep brain stimulation is generally use to treat Parkinson’s plus syndromes. PD is a neurodegenerative disorder in which brain cells progressively die.

Neurostimulation devices market taxonomy:

Global Neurostimulation Devices Market by Type of Device

• Deep Brain Stimulators
• Gastric Electric Stimulators
• Sacral Nerve Stimulators
• Vagus Nerve Stimulators
• Spinal Cord Stimulators
• Others

Global Neurostimulation Devices Market by Application

• Parkinson's Disease
• Depression
• Essential Tremor
• Urinary and Fecal Incontinence
• Gastroparesis
• Others

Global Neurostimulation Devices Market by Geography

• North America
• Latin America
• Europe
• Asia-Pacific
• Middle East
• Africa

Increase in the prevalence of diseases such as Parkinson’s disease (PD) expected to lead the growth of neurostimulation devices market

According to national institutes of health (NIH), around 50,000 people were suffering from Parkinson disease (PD) in the U.S. each year about half of a million people have the disease. North America account for the largest market for neurostimulation devices and is expected to retain its dominance through the forecast period. This is mainly attributed to high patient awareness level and high healthcare spending in the region. Asia Pacific is projected to be the fastest growing market, mainly due to high prevalence of PD in countries such as India and China.

Browse Research Report At: https://www.coherentmarketinsights.com/ongoing-insight/neurostimulation-devices-market-430

As per stats released by the World Health Organization (WHO), around 6.3 million people worldwide suffered from Parkinson’s disease in 2013. Furthermore, according to Anxiety and Depression Association of America (ADAA), in 2016, people suffering from anxiety disorders are highly treatable. According to the National Institute of Mental Health (NIMH),  10% to 15% worldwide women develop postpartum depression. Major depression includes bipolar disorder which are accompanied by delusions, hallucinations, or paranoia which is called as psychotic depression. These conditions can be effectively treated using neurostimulation devices. According to the National Alliance on Mental Illness (NAMI), around 20% of people in U.S are suffering with major depressive disorder develop psychotic symptoms hallucinations.

Essential Tremor (ET) leads to action tremor, with prevalence rate of up to 10% in the US. It is reported that 85% of the patient lifestyle is affected by this disease. This inadvertently creates a highly conducive environment for growth of the neurostimulation devices market.

On the basis of end user, the Global Neurostimulation Devices Market is classified into the following:

• Hospitals
• Rehabilitation Centers
• Medical Clinic

Some of the major players in neurostimulation devices market are Virtual Medical Centre Inc Neurosigma, Boston Scientific Corporation, St. Jude Medical Inc., NDI Medical, electroCore LLC, Electro Medics, Endostim Inc., and NeuroPace, Inc.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Body Contouring Devices Market - Industry Analysis, Size, Share, Growth, Trends and Forecast to 2025

Body contouring is a process that involves alteration of human body by removal of excess fat pockets, thereby optimizing the human physique. These alterations are generally employed on body parts such as upper arms, thighs, buttocks, torso, and chest. Body contouring helps improve the overall appearance of obese individuals who have previously lost a massive amount of weight and need to get rid of the pendulous fats that has lost elasticity and as a result of which cannot be naturally toned. Body contouring involves use of various processes such as body lifting, body fat transfer, bra line lift, implants, and abdominal etching. Most common procedure for body contouring is body lifting, which is a surgical process that removes the excess fat and sagging skin from body areas such as thighs, buttocks, and stomach. On the other hand, body fat transfer is a process in which fat from one place is removed and transferred to another place, thereby contouring and augmenting the shape of the body. There are various devices present in the market that are used in these fat removal process. These includes devices like skin tightening devices and fat reduction devices.

Request Sample Copy of the Business Report: https://www.coherentmarketinsights.com/insight/request-sample/435

Victims of obesity and bariatric surgery patients being the high probable targets of the global body contouring devices market

Body contouring is usually adopted by obese population or the people who have undergone bariatric surgeries. According to WHO, in 2014, over 1.9 billion adults were reported to be overweight, out of which 600 million were obese. This accounts for 13% share of the total world population and are people that would potentially utilize body contouring facilities. Moreover, the annual report of Bariatric Surgery Registry in 2015, suggests that 120 sites in Australia are performing bariatric surgeries on regular basis leading to high probabilities of this population opting for body contouring.

Non-Invasive Devices segment is expected to dominate the market as there is no physical marks retained post-surgery- Customer satisfaction

The global body contouring devices market can be segmented on the basis of product type and geographical areas.

On the basis of product type, the global body contouring devices market can be segmented as-

1. Non- invasive devices

• Radio frequency lipoplastic devices
• High intensity focused ultrasound lipoplasty devices

2. Minimally invasive devices

• Laser assisted lipolysis devices
• Radio frequency assisted liposuction devices

3. Invasive devices: These includes devices such as Ultrasound assisted liposuction devices

Browse Research Report At: https://www.coherentmarketinsights.com/ongoing-insight/body-contouring-devices-market-435

Europe and Asia as upcoming competitors in the global body contouring devices market

Based on regional segmentation, the global body contouring devices market can be segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is expected to dominate the market owing to increasing inclination of the populace towards high awareness of body posture and shape. Europe and Asia are target markets for non-invasive body contouring devices. Though North America offers tremendous opportunity, the FDA is yet to approve these devices. Moreover, the non- invasive nature and lower costs of these treatments add up to growing sales of body contouring devices in Asian and European countries.

Increasing inclination of the populace, especially in emerging economies, towards maintaining aesthetic appeal creates a highly conducive environment for market growth

The body contouring devices market is majorly driven by increase in the rate of obesity at a global scale. The fact sheet of WHO in the year of 2016 states that the global obesity has more than doubled since 1980. The other factors driving the market include advancements in the field of aesthetics and increasing awareness among people regarding fitness. However, the high treatment costs of body contouring could hinder the market growth. The reimbursement policies of these procedures does not include the cost of aesthetic products that are used in the process which is another restraint for the global body contouring devices market.

The key players operating global body contouring devices market are Cynosure, Meridian Co. Ltd., Syneron Medical Ltd., Lumenis, Alma Lasers, Ltd and Palomar Medical Technologies.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Autologous Stem Cell and Non-Stem Cell Based Therapies Market- Industry Analysis, Size, Share, Growth, Trends and Forecast to 2025

Autologous stem-cell transplantation (also known as autogeneic, autogenic, or autogenous stem-cell transplantation or auto-SCT) is the autologous transplantation of stem cells—which is, transplantation in which the undifferentiated cells or stem cells (cells from which other types of cells develop) are taken from a person, accumulated, and given back to the same person later. Even though it is most often executed by means of hematopoietic stem cells (antecedent of cells that forms blood) in hematopoietic stem cell transplantation, in some cases cardiac cells are used productively to fix the damages due to heart attacks. Stem cell transplantation can be of two types - Autologous stem-cell transplantation and allogenic stem cell transplantation. In the later, the recipient and the donor of stem cells are dissimilar people. In a good number of allogeneic transplants, the stem cells are taken from a donor whose cell type matches closely with the patient’s cell type. The best donor in allogenic stem cell transplantation is an immediate family member, generally a brother or sister. If the patient does not have a match in his/her family, a donor may be found from the public. This is often called a MUD or matched unrelated donor transplant. This type of transplant (MUD) is generally riskier.

For More Information, Request sample copy of Business Report: https://www.coherentmarketinsights.com/insight/request-sample/523

Autologous stem cell and non-stem cell based therapies market Taxonomy

On the basis of application, the global autologous stem cell and non-stem cell based therapies market is classified into:

• Neurodegenerative diseases
• Cardiovascular diseases
• Cancer and autoimmune diseases
• Skin transplantation
• Infectious disease

A primary driver for this market is the worldwide increase in occurrence of diabetes and cancer, across all age groups. Furthermore, increasing old-age population is another driver, which is anticipated to create a high growth scenario for the market.

Alternatively, factors restraining the market are complications and risks associated with the treatment including diarrhea, nausea, hair loss, vomiting, severe infections, infertility, and heart complications.

Increasing prevalence of cancer will drive the overall autologous stem cell and non-stem cell based therapies market

According to a report by National Cancer Institute, in 2016, around 1,685,210 new cases of cancer were diagnosed in the U.S. alone. Moreover, it was also noted that around 595,690 people died from the disease in the same year. Autologous stem cell and non-stem cell based therapies is likely to become one of the preferred treatment for cancer. As the prevalence of cancer is rising at a considerable rate, the market is likely to grow during the forecast period.

Browse Global Strategic Business Report: https://www.coherentmarketinsights.com/ongoing-insight/autologous-stem-cell-and-non-stem-cell-based-therapies-market-523

North America, followed by Europe accounted for the major share of the autologous stem cell and non-stem cell based therapies market. This is due to minimization of risks related with the treatment. Moreover, the demand for these treatments is high due to their ability to cure a significant number of infectious diseases. Autologous stem cell and non-stem cell based therapies do not need an outside donor; therefore the treatment is less infectious and convenient. These factors are likely to boost the growth of the market in North America. However, Asia Pacific is expected to show the maximum growth in the forecast period. The demand in this region will be lead by countries such as China, India, Malaysia, and Vietnam. The demand is likely to grow as autologous stem cell and non-stem cell based therapies aid in the efficient management of cardiovascular diseases as well. Growing healthcare infrastructure as well as encouraging tax and reimbursement procedures is also expected to help in the growth of the autologous stem cell and non-stem cell based therapies market in the Asia Pacific.

Key players in the global autologous stem cell and non-stem cell based therapies market are investing heavily in their research and development activities so as to gain an upper hand in the market. Some of the major players operating in the market are NeoStem, Inc., Aastrom Biosciences, Fibrocell Science, Inc., Genzyme Corporation, BrainStorm Cell Therapeutics, Regeneus Ltd., and Dendreon Corporation.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Pharmacy Automation Market - Industry Analysis, Size, Share, Growth, Trends and Forecast to 2025

Pharmacy automation is a mechanical process where handling and distribution of medications takes place in hospital pharmacy or at retail pharmacy. It includes any pharmacy task that involves counting of small objects such as tablets or capsules, measuring and mixing of powders and liquids for compounding, tracking and updating customer information in databases such as personally identifiable information (PPI), drug interaction risk detection, medical history and inventory management. The pharmacy automation market is expected to favor the growth owing to features such as system integration, which increases the productivity and time to clinicians for patient care.

For More Information, Request sample copy of Business Report: https://www.coherentmarketinsights.com/insight/request-sample/472

Furthermore, demand for pharmaceutical products, technologically advanced robotic equipment and tools to perform operations at faster rate pharmacy automation is required in the near future. Whereas, constant developments in technology favors dispensing of prescription medications safer, more accurate and more efficient. Pharmacy automation has helped to provide improved workflow and efficiency to pharmacist as pharmacy automation can manage over 200-300 medications and patient information in an effective and secure manner. Furthermore, increasing government initiatives to improve healthcare infrastructure in emerging economies such as India and China is in turn expected to fuel growth of the pharmacy automation market.

Pharmacy Automation Market Taxonomy

By Product Type

• Automated Medication Dispensing
• Automated Storage and Retrieval Systems
• Automated Packaging and Labeling
• Tabletop Tablet Counter
• Automated Compounding Devices

By End-User

• Retail Pharmacy
• Hospital Pharmacy

Increase in need to reduce medication errors fuels the pharmacy automation market

Medication errors such as failure in the drug prescription or dispensing process is lethal to patients, which occurs due to increase in number of customers and work load on pharmacist that encourages the pharmacist to buy pharmacy automation. Whereas pharmacy automation systems in hospital or at retail pharmacy manages, track drug, supplies health information related to patient so that replenishing of only  required items is performed. Additionally, pharmacy automation market is expected to gain traction due to its transparent tracking systems as pharmacy automation accurately maintain the record of medications expiry date and physical quantities which helps to reduce the medication error. According to National Coordinating Council for Medication Error Reporting and Prevention (NCC MERP) around 0.1 million people die annually due to medical errors in hospital in 2014.

Browse Research Report At: https://www.coherentmarketinsights.com/ongoing-insight/pharmacy-automation-market-472

Regional growth engines for pharmacy automation market

Increase in number of drug prescriptions at pharmacies due to growth in aging population in North America and increase in insurance coverage in the U.S. has elevated the burden from healthcare system of the country, which has highlighted that there is need of improvement in management of work, which is possible by using pharmacy automation.

Furthermore, rapid rise in number of patients and demand for quality care is expected to have a positive impact and also increase in technology advancement in healthcare IT infrastructure also boost the pharmacy automation market in Latin America, Middle East, Africa and Asia Pacific.

Request a Customization: https://www.coherentmarketinsights.com/insight/request-customization/472

Key players to support pharmacy automation market

Technological advancement in pharmacy automation systems have improved pharmacy operation which leads to competition in various manufactures to innovate the product. For example Becton Dickinson and Company developed Cato Mediation Workflow software with an optional camera-based visual documentation hardware that provides visual documentation of syringe, vial and IV container information. Key player operating in pharmacy automation market include Baxter International Inc., Cerner Corporation, Becton Dickinson and Company, McKesson Corporation, Swisslog Holdings AG, Capsa Healthcare, ScriptPro LLC, Yuyama Co., Ltd., Omnicell Inc. and Talyst, Inc.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Pulse Oximeter Market - Industry Analysis, Size, Share, Growth, Trends and Forecast to 2025

Pulse oximeter is a noninvasive device used for monitoring a person’s oxygen saturation (SO2). In its most common application mode, a sensor device is placed on thin part of the patient body, which is usually a fingertip or earlobe in adults and in case of infants it is placed across a foot. The pulse oximeter displays the percentage of blood that is loaded with oxygen. Pulse oximeter specifically measures the percentage of hemoglobin, the protein in blood that carries oxygen. Pulse oximeter is particularly convenient for continuous measurement of blood oxygen saturation noninvasively. Pulse oximeter can be used in any setting where patient’s oxygenation is not stable such as in intensive care, recovery, operating, emergency and hospital ward, pilots in unpressurized aircraft, patient at high altitude for assessment of any patient’s oxygenation and to determine whether there is need for supplemental oxygen.Furthermore, the simplicity of use and ability to provide continuous and immediate oxygen saturation values makes pulse oximeters of critical importance in emergency medicine or first aid. Pulse oximeter

Furthermore, the simplicity of use and ability to provide continuous and immediate oxygen saturation values makes pulse oximeters of critical importance in emergency medicine or first aid. Pulse oximeter are useful for patients with cardiac problem, respiratory problem and chronic obstructive pulmonary disease.

Request Sample Copy of the Business Report: https://www.coherentmarketinsights.com/insight/request-sample/467

Moreover, pulse oximeter are used for diagnosis of sleeping disorders such as hypopnea and apnea. The pulse oximeter with portable battery are useful for pilots operating in a non-pressurized aircraft where supplemental oxygen is required. Pulse oximeter are also used extensively used by mountain climbers and athletes whose oxygen level may decrease at high altitude or with extensive workout.

Pulse Oximeter Market Taxonomy

BY PRODUCT TYPE

• Table-top/Bedside Pulse Oximeters
• Fingertip Pulse Oximeters
• Wrist-worn Pulse Oximeters
• Handheld Pulse Oximeters
• Pediatric Pulse Oximeters

By End Users

• Hospitals
• Healthcare Facilities
• Ambulatory Surgical Centers
• Homecare

Driving forces for the growth of pulse oximeter market in the near future:

Enhancement in healthcare workers to efficiently adopt the improved and reliable detection algorithms, increasing awareness and high prevalence of diseases that require continuous monitoring are the driving forces of pulse oximeter market.

Furthermore, pulse oximeter market is also driven by technology advancements and also in expansion of clinical applications such as in critical care, childbirth, neonatal, surgery, anesthesia and pediatric care. Increasing demand for pulse oximeter is mainly linked to its portability, connectivity, and small size.

Moreover, increase in aging population according to International Journal of Health Policy and Management showed periodic increase during 2004-2012 of aging associated increase in hospitalization, which was pegged at 1.03 million globally. This in turn is expected to favor growth of the pulse oximeter market. Standardization of patient monitoring in clinical practice creates a highly conducive environment for growth of the global pulse oximeter industry. Growing use of alternate care facilities and development in R&D also drives the market of pulse oximeter. However, according to National Sleep Foundation, in 2012, around 40 million people in the U.S. suffered from chronic sleep disorder which suggest the increased use of pulse oximeter.

Browse Research Report At: https://www.coherentmarketinsights.com/ongoing-insight/pulse-oximeter-market-467

Regional growth engines of the pulse oximeter market

According to Centers for Disease Control and Prevention (CDC) and American Academy of Pediatrics (AAP) in September 2014 mandatory critical congenital heart defects (CCHD) screening for new born is a key reason for dominance of U.S for market of pulse oximeter market. Asia Pacific is assumed to observe fastest growth in near future due to increase in investment of industry player in this region is a key reason for growth of market. According to The European Sleep Apnea Database (ESADA), of March 2014, the number of enrollment of patients has reached to 15,956 along with 5313 follow up visits which shows that pulse oximeter market is rising in Europe

Major players operating in pulse oximeter market

There are few big brands that are expected to favor the growth of pulse oximeter market. The Apple watch used pulse oximeter technology for its heart rate monitor which has increased the market size of pulse oximeter. Key players operating in pulse oximeter market are CAS Medical Systems Inc., Covidien Plc, Masimo Corporation, Nihon-Kohden Corp., Nonin Medical Inc., Opto Circuits Ltd., Criticare Systems Inc., Mediaid Inc., Spacelabs Health care Inc., Philips Healthcare and Welch Allyn Inc.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Excimer Laser Devices Market - Industry Analysis, Size, Share, Growth, Trends and Forecast to 2025

An excimer laser, or exciplex laser, is an ultraviolet form of laser. Excimer laser devices find application in eye surgery, production of microelectronic equipment, micromachining, and manufacturing of semiconductor based integrated circuits or chips. An excimer laser mainly consists of reactive gases such as fluorine or chlorine coupled with noble gases, including argon, krypton, and/or xenon. Unlike conventional lasers, laser action in an excimer laser arises from repulsive or dissociative ground state as opposed to being in an excited state. This is due to the fact that noble gases such as krypton and xenon are highly inactive and generally do not form chemical compounds. Nevertheless, when they are in an excited state (induced by a high energy electron beam or an electrical discharge), they can form momentarily bound molecules with themselves known as dimmers or with halogens such as fluorine or chlorine, known as complexes. The compound in its excited state can release its excess energy by undergoing stimulated or spontaneous emission, thereby giving rise to a strongly repulsive molecule in its ground state which dissociates into two unbound atoms on the order of a picoseconds. This is the basic functioning of an excimer laser device.

Request Sample Copy of the Business Report: https://www.coherentmarketinsights.com/insight/request-sample/462

The key industrial use of the excimer lasers is in microelectronic devices and equipment along with ultraviolet photolithography. Excimer lasers have significantly high power ultraviolet output which makes it very useful for surgeries. This is acting as a driving factor for the growth of the excimer laser devices market. Moreover, excimer lasers also find its application in research laboratory equipment. Most important applications of excimer lasers are photolithography for semiconductor chips, laser ablation, micro-structuring of transparent media, pulsed laser deposition, eye surgery, laser marking, psoriasis treatment and dye-laser pumping.

Excimer laser devices market Taxonomy

On the basis of application,

• Coronary Atherectomy
• Peripheral Vascular Disease
• Removal of Cardiac Leads
• Acute Myocardial Infarction and Saphenous Vein Grafts
• Removal of Artery blockages

On the basis of end-user,

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers
• Others

Rising research activities and technological advancements in the area of excimer lasers, some advanced and innovative lasers have been introduced in the market and they are likely to shape the market in the near future. Advanced excimer lasers predominantly offer a combination of high pulse energy and short pulse duration in the UV lengths generated. These attributes pool together to offer an exclusive photonics tool mainly used in LTPS or low temperature poly-Si annealing in FPD or flat panel displays, surface hardening in automotive sector, laser deposition in thin film manufacturing, and patterning in packaging markets.

Rising number of surgeries and high application areas of excimer lasers will drive the overall excimer laser devices market

The lifespan of an excimer laser is mainly limited by gas contamination, corrosion processes, dust produced by electric discharge, apart from high voltage electronics. These are some of the restraining factors that might affect the market negatively during the forecast period. However, varied application areas of excimer laser devices such as medicine, construction, and semiconductor is likely to encourage the growth of the excimer laser devices market during the forecast period.

Browse Research Report At: https://www.coherentmarketinsights.com/ongoing-insight/excimer-laser-devices-market-462

In 2016, North America held the maximum share of the market. The U.K., Germany, France, and Italy are some of the other countries which have a significant share of the market. The increasing volume of surgical procedures across the globe is likely to drive the overall growth of the digital wound management devices market during the forecast period. Surgeries are conducted to mange various diseases including gastrointestinal diseases, cardiovascular diseases, spinal abnormalities, urological disorders, orthopedic deformities, and brain tumors. The significant growth in the number of surgeries, especially in the European countries will help in the growth of the excimer laser devices market in this region. In the Asia Pacific region, Japan, China, India, and South Korea are the leading market players. In South America region, Brazil and Argentina are likely to boost the excimer laser devices market in this region.

Some of the major companies operating in the excimer laser devices market are Alcon, Inc., Coherent, Inc., NIDEK Co. Ltd., Wavelength Opto Electronic (S) Pte Ltd., Laser 2000 GmbH, AMS Technologies AG, Ziemer Opthalmic Systems AG, and Radiant Dyes Laser & Accessories GmbH.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Generic Oncology Sterile Injectables Market - Industry Analysis, Size, Share, Growth, Trends and Forecast to 2025

Generic oncology sterile injectables are used to treat cancer, as these help shrink the tumors. Generic oncology drugs are typically administered intravenously, which kill cells that multiply rapidly, a characteristic of most cancer cells. These drugs are highly effective against various types of cancer such as lymphoma, testicular, cervical, and pancreatic cancers. Most generic oncology sterile injectables are not purchased directly and are instead purchased through health care providers such as hospitals and in some cases from physicians.

Request Sample Copy of the Business Report: https://www.coherentmarketinsights.com/insight/request-sample/562

Approximately, half the market is generic and the proportion of the market is expected to increase due to its low price. Whereas, as the life sciences firms have increased their focus to therapeutic segments like oncology. Moreover, there are various generic oncology sterile injectables based on conventional chemotherapy, as it is a backbone of cancer treatment. Furthermore, the generic oncology sterile injectables is focused on cytotoxics and advanced formulation. Generic oncology sterile injectables are also highly specialized class of product and are difficult to produce due to toxic characteristic, which also needs sterile environment and containment of the raw material and product during the development and production process.

Generic Oncology Sterile Injectable Market Taxonomy

By Drug Type

• Monoclonal Antibodies
• Cytotoxic Chemotheraphy
• Methotrexate
• Mitoxantrone
• Oxaliplatin
• Paclitaxel
• Others
• Vaccines
• Preventive(Or Prophylactic) Vaccines
• Treatment (Or Therapeutic) Vaccines
• Immunoglobulins
• Blood Factors
• Peptide Antibiotics

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

By Disease Indication

• Ovarian Cancer
• Breast Cancer
• Lung Cancer
• Pancreatic Cancer
• Others

Rise in prevalence of cancer is expected to fuel the growth of generic oncology sterile injectable market

According to Centers of Disease and Prevention Control (CDC) in 2016, 21.1 million cases of cancer were reported among adults in the U.S., which is expected to fuel growth of the market of generic oncology sterile injectable in near future. Whereas, 70% of U.S. hospital patients receive a generic injectable drug, which also drives market growth. Whereas, the U.S. Food and Drug Administration (FDA) also approves the generic drug which is bioequivalent to the brand name drug in dosage form, safety, strength, route of administration, quality, performance characteristics and intended use, which is expected to boost the generic oncology sterile market. Various patients are treated with safe, high-quality and effective generic oncology sterile injectables, as generic oncology sterile injectable can cost up to 90% less than branded drugs. Moreover, generic oncology sterile injectables is expected to contribute towards cost savings for cancer medications.

Browse Research Report At: https://www.coherentmarketinsights.com/ongoing-insight/generic-oncology-sterile-injectables-market-562

Regional growth engines of the generic oncology sterile injectable market

On the basis of regional segmentation, the generic oncology sterile injectable market can be segmented into North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Due to increase in prevalence of cancer in the U.S., North America is expected to dominate the generic oncology sterile injectable market. According to W.H.O., cancer is one of the leading cause of morbidity and mortality worldwide, with approximately 14 million new cases in 2012. This is advertently fueling market growth. Furthermore, according to The Cancer Atlas, top 5 countries with highest estimated number of cancer cases were in Asia Pacific in 2012. This makes the region a major growth engine of the generic oncology sterile injectable market.

The key players dominating the generic oncology sterile injectable market

The key players operating in the generic oncology sterile injectable market include Eli Lily and Company, Biocon, Baxter International Inc., Hikma Pharmaceuticals PLC, Mylan N.V., Sandox Pvt Ltd, Uman Pharma, Inc., and Pfizer, Inc.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Knee Braces Market - Industry Analysis, Size, Share, Growth, Trends and Forecast to 2025

Knee bracing devices are orthopedic tools that are mainly used for alignment, pain reduction and maintenance of structural and functional characteristics of the knee. Knee braces offer protection to the knees of patients suffering from osteoarthritis as well as are used in the treatment of meniscus injuries. Apart from these, knee braces can be used as safety devices while playing various sports such as running and soccer and are also used in injury rehabilitation. These are generally worn in case of knee pain. Knee braces are made from one or more combination of rigid and flexible materials like metal, plastic, moldable foam, synthetic rubber, padding or elastic material and straps. These knee braces are available is several sizes and have provisions for pressure adjustments. On the other hand, custom knee braces are designed in a way to perfectly fit the exact knee measurements.

Request Sample Copy of the Business Report: https://www.coherentmarketinsights.com/insight/request-sample/440

Increasing Knee injuries along with Osteoarthritis contributing to the boost of global knee braces market

The knee braces consumption is mostly driven by patients suffering from osteoarthritis. According to WHO, over 20% of the world’s population aged over 60 that accounts for around 130 million people will suffer from osteoarthritis by the 2050. Additionally, the National Institute of Health reported 6,664,324 knee injuries in the U.S. from 1999 to 2008 and is expecting a significant in increase in this number by 2020. These estimates suggests a drastic boost for the global knee braces market during the forecast period.

The global knee braces market can be segmented on the basis of product type, end user and geographical regions.

On the basis of types of braces available,

1. Rehabilitative braces: These are involves in providing stability to allow a limited movement while an injury is healing.
2. Unloader braces: These braces are generally used by people suffering from arthritis to relieve the pain.
3. Prophylactic braces: These are the protective braces generally worn to avoid knee injuries during sports. These braces are commonly used by athletes.
4. Knee Sleeves: These are support devices that are used to provide compression around the knee joints are used for knee support and controlling pain and swelling around the knee area.

Based on the end user,

• Hospitals
• Clinics
• Orthopedic Centers
• Rehabilitation Centers
• Others

North America to hold largest share of the global knee braces market owing to increased osteoarthritis cases

On the basis of regional segmentation, the knee braces market can be segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is the largest shareholder of the global market, followed by Europe. According to Centers for Disease Control and Prevention (CDC), around 30 million adults in the U.S. are affected with osteoarthritis in 2016 suggesting high consumption of knee braces for the treatment of this disease in the U.S. Moreover, developing countries such as China, Japan and India are emerging as potential regional competitors to build a strong market share in the global knee braces industry due to improvement in healthcare infrastructure, government revenue towards developing safety facilities and orthopedic facilities, awareness about importance of maintaining good health among the people and rise in the rates of obesity.

Browse Global Strategic Business Report: https://www.coherentmarketinsights.com/ongoing-insight/knee-braces-market-440

High incidence rates of osteoarthritis and meniscus injuries are responsible for driving the global knee braces market

The prevalence and incidence rate of Osteoarthritis and meniscus injuries among the geriatric population are the primary reasons to drive the global knee braces market. The United Nations suggests that number of people aged over 60 years is projected to grow by 56%, accounting a rise from 901 million to 1.4 billion in the years 2015 to 2030. Moreover, according to the CDC data in 2015, 23.7 million adults in the U.S. have functional limitations in their regular movements due to doctor diagnosed arthritis suggesting strong probabilities of prevalence of osteoarthritis. Other factors that are responsible for driving global knee braces market includes knee injury, meniscus injury, use of knee braces as preventive measures to avoid knee injuries by sport players and athletes and people with genetic effects that have defects in natural collagen production leading to knee pain.

The key players dominating the global knee braces market includes Alex Orthopedic Inc., Body Sport, Bell Horn, Cho-Pat, DJO Global, Medi-Dyne and Medline. These companies are holding a strong position in the global knee braces market due to high R&D investment costs and long term contract relationship with the customers.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Parkinson’s Disease Therapeutic Market - Industry Analysis, Size, Share, Growth, Trends and Forecast to 2025

Parkinson’s disease (PD) is a chronic disorder characterized by the malfunctioning and death of vital nerve cells in the brain, and can be characterized by tremor, dementia, and depression. Parkinson’s disease progression leads to uncontrolled body movement of the patient. There is no cure presently for parkinson’s disease only treatments options such as medication and surgery to manage the symptoms are available. Parkinson’s disease mainly affects people over 50 and the risk increases with increasing age. Parkinson’s disease treatment is used to control symptoms such as uncontrolled movement, shakiness of hands, and some others. The therapeutic approaches like levodopa in combination with carbidopa is considered as an effective treatment over symptoms of Parkinson’s disease. The surgical treatment option is available but it is only effective for patients who are previously responded to levodopa therapy. The research and development in the field of Parkinson’s disease therapeutic will help in the treatment of Parkinson’s disease.

Request Sample Copy of the Business Report: https://www.coherentmarketinsights.com/insight/request-sample/494

Increase in prevalence of Parkinson’s disease across the world is driving the Parkinson’s disease therapeutic market

According to Parkinson’s disease foundation, more than 10 million people globally are living with Parkinson’s disease and 60,000 Americans are diagnosed with Parkinson’s disease each year. The rising prevalence of Parkinson’s disease across the world is one of the major factor which is driving the Parkinson’s disease therapeutic market. Rising male patients, is also the major factor owing to Parkinson’s disease therapeutic market, because as mentioned in the data of Parkinson’s disease foundation, chances of getting Parkinson’s disease are one and half times more in men than women. The increase in number of geriatric population and technological advancements such as combination therapies for prolong action of continuous dopaminergic stimulation drugs, gene therapy, neural transplantation are some other causes which are likely to drive the Parkinson’s disease therapeutic market. However some restraints like expiry of patents for several drugs such as Stalevo, Azilect, Rytary, Comtan etc. can cause the cessation of Parkinson’s disease therapeutic market.

The advancements in medical devices segment for Parkinson’s disease treatment is expected to boost the growth in Parkinson’s disease therapeutic market

Global Parkinson’s disease therapeutic market is segmented on the basis of treatment type, end user and geographical regions

On the basis of treatment type,

• Medical Devices
• Deep Brain Stimulation (DBS) Devices
• Carbidopa/Levodopa Enteral Suspension (Duopa) delivery devices
• Drug Class
• Dopamine precursors
• COMT Inhibitors
• MAO Inhibitors
• Peripheral Decarboxylase Inhibitors
• Others

On the basis of end user,

• Clinics
• Hospitals
• Homecare Settings

Browse Research Report At: https://www.coherentmarketinsights.com/ongoing-insight/parkinsons-disease-therapeutic-market-494

New advancements in the treatment of parkinson’s disease has helped to boost the growth in North America for parkinson’s disease therapeutic market.

Regional segmentation of Parkinson’s disease therapeutic market according to coherent market Insights comprises of North America, Latin America, Europe, Asia pacific, Middle East, and Africa. High prevalence of Parkinson’s disease and good reimbursement policies are some of factors which allows the North America region to dominate in the Parkinson’s disease market. For instance, over 40 medicines are developed for the treatment of parkinsons disease and many have gained the fast track designation from U.S. Food and Drug Administration (FDA) in North America. North America is expected to hold the largest share in the Parkinson’s disease market because of increase in investments in research and development for Parkinson’s disease.

New product development is the key strategy adopted by major industry player in Parkinson’s disease therapeutic market

Key players in the Parkinson’s disease therapeutics market globally are Salix Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Novartis AG, GlaxoSmithKline Plc., Mylan N.V., Orion Corporation, Boehringer Ingelheim, UCB, and Impax Labs.  Many of the key players involved in the anti-Parkinson’s disease medication and some of the biopharmaceuticals research companies in the U.S. are currently in the development of new medicines for treatment of Parkinson’s disease. The industry players such as Novartis AG, Pfizer, Ceregene, and Biogen are expected to launch new drugs for Parkinson’s disease treatment in the future.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Automatic Cell Imaging System Market - Industry Analysis, Size, Share, Growth, Trends and Forecast to 2025

Live cell imaging, or cell imaging is the examination of living cells using time-lapse microscopy (time-lapse photography applied to microscopy). Cell Imaging is used by scientists to get a better understanding of the biological functions of the body in the course of the study of cellular dynamics. The process was established in first half of the 20th century. The first time-lapse microcinematographic films showed the development and fertilization of a sea urchin egg. Various methods of microscopy have since been developed, thereby allowing researchers to experiment on living cells with greater detail and with less effort. A new kind of imaging, which uses quantum dots, has been pioneered as they are found to be more stable.

Request Sample Copy of the Business Report: https://www.coherentmarketinsights.com/insight/request-sample/499

Cell imaging has become an important tool in medical research. Automatic microscopy and image analysis are used to study a variety of different things such as the influence of chemical compounds on cell development. Researchers in this field primarily want to see which compounds capture the cell cycle or the time they take to incubate and at what concentration. Cell cycle is a rigid sequence of phases that a cell undergoes while it is on its dividing phase. If anything goes wrong at some stage during the transition from one phase to other, the cell generally enters cell death that is programmed. Studying these procedures needs intricate image analysis workflows that can be mind-numbing to ascertain. This process is sped up by the use of modular software. Automated cell imaging also find its usage in the drug discovery processes for various diseases, for instance, cancer drugs. As the prevalence of cancer around the world is rising at an alarming rate, the automatic cell imaging system market is likely to gain significant traction during the forecast period.

Automatic Cell Imaging System Market Taxonomy

On the basis of type of product,

• Phase contrast microscopy
• Fluorescent microscopy
• Quantitative phase contrast microscopy

On the basis of end user,

• Research centers
• Hospitals
• Others

High prevalence of cancer will drive the overall automatic cell imaging system market

According to the National Cancer Institute, an estimated 1,685,210 new cases of cancer were diagnosed in the U.S. alone and around 595,690 people died from the disease in 2016. The most common cancers were breast cancer, colon and rectum cancer, kidney and renal pelvis cancer, prostate cancer, non-Hodgkin lymphoma, leukemia, thyroid cancer, lung and bronchus cancer, melanoma of the skin, bladder cancer, pancreatic cancer, and endometrial cancer. The quantity of new cases of cancer was 454.8 per 100,000 women and men per year (statistic based on 2008-2012 cases). Additionally, the number of deaths due to cancer was 171.2 per 100,000 women and men per year (statistic based on 2008-2012 cases). As the occurrence of cancer is rising at an alarming rate, so is the need for automatic cell imaging system. Automatic cell imaging system offers grass root level analysis of the division of cancer cells and hence researchers are using this technique to find a cure to the fatal disease. This is likely to fuel the growth of the overall automatic cell imaging system market.

North America held the maximum market share in automatic cell imaging system market globally. Favorable and constructive policies and regulations as well as availability of sophisticated healthcare facilities along with rising approvals about the usage of automatic cell imaging system from the governing bodies are likely to fuel the growth of the automatic cell imaging system market in this region.

Browse Research Report At: https://www.coherentmarketinsights.com/ongoing-insight/automatic-cell-imaging-system-market-499

The automated microscopy process generates hundreds and thousands of images in a matter of few days; hence, potent image analysis software is required to differentiate between the various appearances of the cell. Manufacturers of automated microscopes generally offer image analysis software for the analyzing of the images that are produced by their hardware. The complexity with this software is to discover the right approach for a definite assay. The analysis desires robustness in order to cope with various situations and they should be fast enough to compute the results for the huge amount of images generated in a short time. Some of the key players operating in the global automatic cell imaging system market are GE Healthcare Life Sciences, West Medica, Norma Diagnostika GmbH, Bioview, Caliber I.D., Molecular Devices, BioTek Instruments, and PerkinElmer.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

ENT Chairs Market - Industry Analysis, Size, Share, Growth, Trends and Forecast to 2025

ENT is an area of medicine dealing with treatment of human body parts namely ear, nose, and throat (ENT) and few related areas such as neck and face. The medical disorders treated by ENT physicians include chronic ear infection, sinusitis, snoring, sleep apnea, hearing loss, allergies, hay fever, swallowing disorders, nosebleeds, hoarseness, dizziness and neck cancer. Ear, nose and throat specialists or otolaryngologists have specific tools for treating patients well as using general surgery instruments and devices. These highly customized ENT chairs are designed according to the need of orthopedic comfort. ENT chair consists of three main parts, namely, back rest, seat, and leg rest. ENT chair helps in mobility of patient or improvement in comfort during various surgical operation. ENT chair market is expected to witness strong growth due to increase in number of private and government clinics and hospitals in last few years.

Request Sample Copy of the Business Report: https://www.coherentmarketinsights.com/insight/request-sample/504

Furthermore, ENT chair includes features such as height-adjustable, reclining, adjustable backrest, tilting and convertible. ENT chairs operations can be performed by following mechanics mechanical, electric, hydraulic, electromechanical and elctro-hydraulic. ENT chairs is basic necessity of otolaryngologist. Moreover, increase in number of otolaryngologists is expect to support the growth in ENT chairs market over the forecast period.

ENT Chairs Market Taxonomy

By Product Type

• Manual ENT Chair
• Programmed ENT Chair

By End Users

• Hospital
• Clinics

Otolaryngologist fuels the growth of ENT chairs

Otolaryngology is the oldest medical specialty in U.S. Otolaryngologists are physicians trained in medical and surgical management and treat patients with diseases and disorders of the ear, nose, throat (ENT) and related structure of face and neck. Increasing in the number of such diseases are expected to fuel the market of ENT chairs. According to Centers for Disease Control and Prevention (CDC) around 30.0 million people were diagnosed with sinusitis which was about 12.1% of adults of the U.S. population in 2015 which significantly shows that there is rise in market of ENT chairs. Also 360 million people worldwide have disabling hearing loss and 32 million of these are children according to W.H.O in 2016 which also fuels the market of ENT chairs.

Regional growth engines of ENT chair market

Approximately one third of the people over 65 years of age are affected by disabling hearing loss and according to W.H.O prevalence of this age group was greatest in South Asia, Asia Pacific and sub-Saharan Africa.  Whereas in the U.S. there were 9,642 otolaryngologists in practice according to ENT journal in 2013 which determine that there is growth in market of ENT chair in U.S. 

Browse Research Report At: https://www.coherentmarketinsights.com/ongoing-insight/ent-chairs-market-504

Key players supporting the growth of ENT chair market

Manufactures are focused on offering advanced features to ENT chairs at affordable prices to gain a competitive edge in the market. Growing number of individual clinics further augments is increasing the market of ENT chair. Key players operating in global ENT chair market include Atmos Medical, Heinemann Medizintechnik, Haag Streit, Optomic, Chammed, Global Surgical, BOKEER, Mega Medical, Nagashima Medical, Arsimed Medical, Innotech Medical and Olsen.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Medical Specialty Bags Market - Industry Analysis, Size, Share, Growth, Trends and Forecast to 2025

Medical specialty bags are specially designed bag for use in various medical areas such as in the collection and storage of blood samples, urine collection, enteral feeding and sterile packaging. This bags are most probably used in hospitals for the maintenance of sterilized condition of blood sample which helps in control of disease spreading and in leakage of medicines or blood samples. Blood bags are sterile bags and are nontoxic or reduce the toxicity and can store the blood for a relatively long period. Therefore, they are used in blood collection and storage of blood, especially in blood banks.

Request Sample Copy of the Business Report: https://www.coherentmarketinsights.com/insight/request-sample/509

The anesthesia breathing bags are the breathing bags used with face mask that can be placed over the mouth and nose of the patients and provides oxygen for complete breathing. This bags are squeezed and pushes the oxygen flow in the patient’s lungs. This helps in reducing fatigue of hands and also provides firm grip to the hands and are comfortable in use for the patients. This bags are available in various size and are made up of thin durable designs. The ostomy collection bags are used in collection waste from surgically diverted biological system such as colon, ileum, and bladder as ostomy bags are airtight and watertight.

Medical specialty bags market taxonomy

Medical Specialty Bags Market by Product Type:

• Anesthesia breathing bags
• Bile collection bags
• Blood bags
• Continuous ambulatory peritoneal dialysis (CAPD) bags
• Enema bags
• Enteral feeding bags
• Intravenous fluid/infusion bags
• Ostomy collection bags
• Resuscitation bags
• Urinary collection bags
• Others

Medical Specialty Bags Market by Geography:

• North America
• Latin America
• Europe
• Asia Pacific
• Middle East
• Africa

Rise in the prevalence of high blood pressure and increase in chronic kidney disease globally expected to boost the growth of medical specialty bags market

The rise in global aging population, rise in chronic disease cases, increase in health care expenditure and disposable income are the major factors leading to the growth of the medical specialty bags market. Moreover, rise in blood infusion emergencies and increased use of blood bags further augments market growth.

Browse Research Report At: https://www.coherentmarketinsights.com/ongoing-insight/medical-specialty-bags-market-509

Geographically North America holds the largest market in the medical specialty bags market. Due to the high prevalence of diseases, increase in obesity population, acceptance in new and innovative products and better infrastructure investments support of health care facilities are the major factors driving the growth of medical specialty bags market in North America.

Centers for Disease Control and Prevention (CDC), in 2017 around 30 million (15%) U.S. adults are estimated to have chronic kidney disease and around 48% of those with severely reduce kidney function, and 96% people are suffering with kidney damage. As there is a strong economic growth in this country, rapid growth of medical infrastructure, rise in disposable income and increase in awareness and demand for healthy life, which has led to increase the demand for medical specialty bags.

Rise in incidence of blood infusion emergencies and introduction of PVC free bags is the major factor that drive the blood bag market. This bags are general used for the blood samples collections or for the storage during the heart surgery period. According to the World Health Organization (WHO), worldwide it was estimated that around 7.5million deaths occurred due to high blood pressure. As per Heart Foundation it was estimated that around 4.6 million (32%) Australians aged 18 years and over had high blood pressure in 2012, and out of this around 23.6% women were more likely to have uncontrolled high blood pressure.

Major Market Players of Medical Specialty Bags Include:

• Braun Melsungen AG,
• Baxter International, Inc.
• Coloplast A/S
• ConvaTec, Inc.
• Hollister Incorporated
• Medline Industries Inc.
• Nolato AB
• Bard, Inc.
• Macopharma SA
• Terumo Corporation
• Smiths Medical
• Fresenius SE & Co. KGaA

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.